This Houston hospital is tapping into tech to best optimize its COVID-19 vaccination process. Photo courtesy of MD Anderson

Across the country, millions of people eagerly await their COVID-19 vaccinations. But many of them are encountering a big roadblock on the path toward eradicating the pandemic: scheduling their shots.

To overcome that hurdle, some organizations have turned to technology. San Antonio-based grocery chain H-E-B, for instance, will let customers schedule COVID-19 vaccinations through a web-based scheduler. As with H-E-B's app, many vaccination-scheduling tools are just now becoming available.

Houston's MD Anderson Cancer Center is one huge step ahead of the vaccination curve, though. Back in September, the hospital — part of the massive Texas Medical Center complex — started planning how it would roll out vaccinations for its more than 21,000-member workforce. As part of that planning, MD Anderson developed an in-house app enabling its employees to schedule their own vaccination appointments.

"We have an incredible team of informatics developers who worked in conjunction with our human resource and employee health leaders to design an app that's accessible on your phone or from any computer," says Dr. Welela Tereffe, chief medical executive at MD Anderson. "The app feeds you information about what appointments are available and then floats an appointment reminder to your calendar as well as sending you text reminders."

Beginning December 15, MD Anderson employees received the hospital's initial round of shots. They were the first employees who used the app to schedule appointments at workplace vaccination clinics. As of January 5, more than 8,700 hospital employees had been vaccinated with the first dose of either the Pfizer vaccine or Moderna vaccine. The immunizations are not mandatory. In all, 10,700 doses of COVID-19 vaccine have been shipped to MD Anderson since December 14, and every one of them is already spoken for.

Yolan Campbell, associate vice president of HR operations at MD Anderson, says the vaccination scheduling app built on knowledge the hospital's team had accumulated throughout 2020 in producing apps for COVID-19 tests and other pandemic-related purposes.

Tereffe notes that COVID-19 vaccination scheduling has "caused a lot of stress" for health care providers. MD Anderson hoped to avoid that stress by incorporating the app into its vaccination plan.

"The app that that our teams have designed is very simple, very user-friendly," Tereffe says. "It prompts you to put in your preferred contact information, both email and phone. It allows you to choose a block of time and a day that you'd like to be vaccinated. And it puts the information right there at your fingertips about the vaccine and the vaccine clinic process so that you can review it in real time."

As soon as an employee chooses an appointment slot, they receive conformation via the app. Through the app, an employee can cancel or reschedule an appointment.

"I think that level of access and control really helps to reassure people that they can trust the process," Tereffe said.

The app also gives MD Anderson more control over the vaccination clinics, according to Campbell and Tereffe. For instance, a dashboard created by IT professionals at the hospital gathers data from the app to track how many vaccinations have been given, how many appointments have been canceled, and which times and days are most popular for vaccinations. Tereffe said those real-time insights have enabled MD Anderson to adjust the operating hours for vaccination clinics.

To supplement the app, MD Anderson provides extra assistance with vaccination scheduling for employees with language or technology barriers, Tereffe said. The hospital also runs a vaccination hotline staffed by HR professionals.

Looking ahead, Tereffe said MD Anderson will accept any COVID-19 vaccine that's been approved by the U.S. Food and Drug Administration (FDA). So far, that's limited to the Pfizer and Moderna versions.

"We have a process in place to hold unique clinics for each type of vaccine and each dose of vaccine to ensure that people get the vaccine that they have chosen … and that they always get the correct second dose," Tereffe said. "Our intent is to help our employees make informed decisions."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New TMC partnership aims to grow Houston’s biomanufacturing workforce

workforce partnership

Houston is a frontrunner in the race to introduce and manufacture advanced therapeutics to the medical world. A new agreement between the Texas Medical Center (TMC) and San Jacinto College (SJC) aims to speed more experts and their technologies towards the finish line.

Earlier this month, the world's largest medical center and the nation’s second-ranked community college announced their new partnership that will set students on a path towards careers not only in life sciences in general, but also in pharmaceutical and biomanufacturing specifically.

SJC already has programs in those majors—its first graduates are now joining the workforce—but working with TMC will help the college recruit new students, as well as aid in enrollment and participation. Thanks to this collaboration, SJC students will benefit from more experiential learning and be able to transition more smoothly into the next steps in their training.

“Houston is a premier global hub for life sciences and biotechnology, and the talent we need to advance therapeutic drugs, diagnostics, and cell and gene therapy is already here,” William McKeon, the TMC’s president and CEO, said in a news release. “With more companies choosing to establish their headquarters in Houston and the daily breakthroughs happening across the TMC campus, partnering with San Jacinto College is an important step toward sustaining that momentum and unlocking even greater innovation and growth through the promising talent that already exists within our state.”

The partnership is currently slated to last two years, but the institutions have the option to extend after that.

For students, their journey to becoming scientists will likely start with Biopath @ TMC, a program that introduces high school students to biomanufacturing careers and what it takes to pursue one. Since its inception two years ago, the program has worked with more than 2,000 students around Harris County.

“This partnership exemplifies San Jacinto College’s ability to design and deliver programs that align with current workforce demands while opening doors for untapped talent across the Houston region,” Brenda Hellyer, SJC chancellor, said in the release. “TMC is a key industry leader in our region, and San Jacinto College has a unique global curriculum that provides the foundation and skills required for students to succeed and graduates to thrive in meaningful careers that will contribute to the innovation and advancement of the life sciences.”

Thanks to this new collaboration, more of Houston’s biomanufacturing workforce will soon be locally grown.

Houston legacy planning platform secures $2.5M investment, adds to board

fresh funding

Houston-based Paige, a comprehensive life planning and succession software company, has secured a $2.5 million investment to expand the AI-driven tools on its platform.

The funding comes from Alabama-based 22nd State Banking Company, according to a news release. Paige says it will use the funding to expand automation, AI-driven onboarding and self-service tools, as well as add to its sales and customer success teams.

The company was originally founded by CEO Emily Cisek in 2020 as The Postage and rebranded to Paige last year. It helps users navigate and organize end-of-life planning with features like document storage and organization, password management, and funeral and last wishes planning.

“Too many families are left trying to piece together important information during some of the hardest moments of their lives,” Cisek said in the news release. “This investment allows us to accelerate the next phase of growth for Paige by improving the product and expanding support for our members, our financial institution partners and the communities they serve,”

In addition to the funding news, the company also announced that 22nd State Banking CEO and President Steve Smith will join Paige's board of directors.

“We believe banking should be grounded in relationships and built around the real needs of the people and communities we serve. Paige brings something deeply relevant to that mission," Smith added in the release. "It helps families prepare for the future in a practical and meaningful way, and it gives the banking community new pathways to support customers through important life transitions.”

Paige estimates that $124 trillion in assets will change hands through 2048. Yet about 56 percent of Americans do not have an estate plan.

Read more on the topic from Cisek in a recent op-ed here; or listen to InnovationMap's 2021 interview with her here.

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.